Steffan Joe's Album: Wall Photos
Cancer Biomarkers
Market by Roots Analysis
Advances in biotechnology have enabled the identification
of several novel biomarkers, which are presently being used for a variety of
purposes, including diagnosis, drug development, clinical research and to
facilitate therapy-related decisions
Roots Analysis is pleased to announce the publication of its recent
study, titled, “Cancer
Biomarkers Market: Focus on TMB, MSI / MMR and TILs Testing,
2019–2030.”
The report features an extensive study of the current landscape
and future outlook of the immuno-oncology biomarkers testing market (focusing
particularly on TMB, MSI and TILs (CD3+, CD4+, CD8+, FOXP3+)). It provides an
in-depth analysis, highlighting the capabilities of the various companies
engaged in this domain. Amongst various elements, the report includes:
§ A detailed
analysis of ongoing, biomarker-based clinical trials initiated by big
pharmaceutical companies.
§ An
analysis of the landscape of companies offering testing services for cancer
biomarkers, namely TMB, MSI / MMR and TILs (including CD3+, CD4+, CD8+ and
FOXP3+).
§ An
insightful 2X2 representation of the results of a detailed competitiveness
analysis of various tests (segregated
across different biomarker groups).
§ Elaborate
profiles of leading analytical testing service providers focused on
immuno-oncology biomarkers (shortlisted
based on strength of service portfolio).
§ A
detailed publication analysis of over 180 research articles that have been
published since 2016, highlighting the key focus areas of ongoing research
activity related to immuno-oncology biomarkers, namely TMB, MSI / MMR and TILs.
§ A
comprehensive clinical trial analysis of completed, ongoing and planned
studies, focused on the assessment of cancer biomarkers, namely TMB, MSI / MMR
and TILs.
§ A
discussion on the upcoming opportunities that are likely to impact the
evolution of this market over the coming years.
§ A
discussion on various steps involved in development operations of companion
diagnostics
§ A
comparative analysis of the needs of different stakeholders involved in the
development of companion diagnostic products
§ A detailed market
forecast, featuring analysis of the current and projected future opportunity
across key market segments (listed below)
Type of test
§ Laboratory
Developed Tests (LDTs)
§ Companion
Diagnostic Tests (CDx)
Type of disease indication
§ Breast
cancer
§ Blood
cancer
§ Colon
/ Colorectal cancer
§ Lung
Cancer
§ Melanoma
§ Prostate
Cancer
Type of cancer biomarker
§ TMB
§ MSI
/ MMR
§ TILs
Type of analytical technique
§ Next
Generation Sequencing (NGS)
§ Polymerase
Chain Reaction (PCR)
§ Immunohistochemistry
(IHC)
§ Others
Key geographical regions
§ North
America
§ Europe
§ Japan
§ China
§ Australia
Key
companies covered in the report
§
Foundation Medicine
§
NeoGenomics Laboratories
§
Novogene
§
Q2 Solutions
§
Personal Genome Diagnostics
§
Dr Lal PathLabs
§
Shenzhen Yuce Biotechnology
For
more information please click on the following link:
https://www.rootsanalysis.com/reports/view_document/cancer-biomarkers-market-focus-on-tmb-msi--mmr-and-tils-testing-2019--2030/253.html
Other Recent Offerings
1.
Global T-Cell (CAR-T,
TCR, and TIL) Therapy Market (4th Edition), 2019-2030
2.
Neoantigen Targeted
Therapies Market,
2019-2030
3.
Companion Diagnostics
Market
(2nd Edition), 2019-2030
4.
Cell Encapsulation: Focus on Therapeutics
and Technologies, 2019-2030
5.
In Vitro ADME Testing
Services Market,
2019-2030
About Roots Analysis
Roots Analysis is one of the fastest growing
market research companies, sharing fresh and independent perspectives in the
bio-pharmaceutical industry. The in-depth research, analysis and insights are
driven by an experienced leadership team which has gained many years of
significant experience in this sector. If you’d like help with your growing
business needs, get in touch at info@rootsanalysis.com
Contact Information
Roots
Analysis Private Limited
Gaurav Chaudhary
+1 (415) 800 3415
ben.johnson@rootsanalysis.com
Facebook - https://www.facebook.com/RootsAnalysis
LinkedIn - https://www.linkedin.com/company/roots-analysis/mycompany/
Twitter - https://twitter.com/RootsAnalysis
Market by Roots Analysis
Advances in biotechnology have enabled the identification
of several novel biomarkers, which are presently being used for a variety of
purposes, including diagnosis, drug development, clinical research and to
facilitate therapy-related decisions
Roots Analysis is pleased to announce the publication of its recent
study, titled, “Cancer
Biomarkers Market: Focus on TMB, MSI / MMR and TILs Testing,
2019–2030.”
The report features an extensive study of the current landscape
and future outlook of the immuno-oncology biomarkers testing market (focusing
particularly on TMB, MSI and TILs (CD3+, CD4+, CD8+, FOXP3+)). It provides an
in-depth analysis, highlighting the capabilities of the various companies
engaged in this domain. Amongst various elements, the report includes:
§ A detailed
analysis of ongoing, biomarker-based clinical trials initiated by big
pharmaceutical companies.
§ An
analysis of the landscape of companies offering testing services for cancer
biomarkers, namely TMB, MSI / MMR and TILs (including CD3+, CD4+, CD8+ and
FOXP3+).
§ An
insightful 2X2 representation of the results of a detailed competitiveness
analysis of various tests (segregated
across different biomarker groups).
§ Elaborate
profiles of leading analytical testing service providers focused on
immuno-oncology biomarkers (shortlisted
based on strength of service portfolio).
§ A
detailed publication analysis of over 180 research articles that have been
published since 2016, highlighting the key focus areas of ongoing research
activity related to immuno-oncology biomarkers, namely TMB, MSI / MMR and TILs.
§ A
comprehensive clinical trial analysis of completed, ongoing and planned
studies, focused on the assessment of cancer biomarkers, namely TMB, MSI / MMR
and TILs.
§ A
discussion on the upcoming opportunities that are likely to impact the
evolution of this market over the coming years.
§ A
discussion on various steps involved in development operations of companion
diagnostics
§ A
comparative analysis of the needs of different stakeholders involved in the
development of companion diagnostic products
§ A detailed market
forecast, featuring analysis of the current and projected future opportunity
across key market segments (listed below)
Type of test
§ Laboratory
Developed Tests (LDTs)
§ Companion
Diagnostic Tests (CDx)
Type of disease indication
§ Breast
cancer
§ Blood
cancer
§ Colon
/ Colorectal cancer
§ Lung
Cancer
§ Melanoma
§ Prostate
Cancer
Type of cancer biomarker
§ TMB
§ MSI
/ MMR
§ TILs
Type of analytical technique
§ Next
Generation Sequencing (NGS)
§ Polymerase
Chain Reaction (PCR)
§ Immunohistochemistry
(IHC)
§ Others
Key geographical regions
§ North
America
§ Europe
§ Japan
§ China
§ Australia
Key
companies covered in the report
§
Foundation Medicine
§
NeoGenomics Laboratories
§
Novogene
§
Q2 Solutions
§
Personal Genome Diagnostics
§
Dr Lal PathLabs
§
Shenzhen Yuce Biotechnology
For
more information please click on the following link:
https://www.rootsanalysis.com/reports/view_document/cancer-biomarkers-market-focus-on-tmb-msi--mmr-and-tils-testing-2019--2030/253.html
Other Recent Offerings
1.
Global T-Cell (CAR-T,
TCR, and TIL) Therapy Market (4th Edition), 2019-2030
2.
Neoantigen Targeted
Therapies Market,
2019-2030
3.
Companion Diagnostics
Market
(2nd Edition), 2019-2030
4.
Cell Encapsulation: Focus on Therapeutics
and Technologies, 2019-2030
5.
In Vitro ADME Testing
Services Market,
2019-2030
About Roots Analysis
Roots Analysis is one of the fastest growing
market research companies, sharing fresh and independent perspectives in the
bio-pharmaceutical industry. The in-depth research, analysis and insights are
driven by an experienced leadership team which has gained many years of
significant experience in this sector. If you’d like help with your growing
business needs, get in touch at info@rootsanalysis.com
Contact Information
Roots
Analysis Private Limited
Gaurav Chaudhary
+1 (415) 800 3415
ben.johnson@rootsanalysis.com
Facebook - https://www.facebook.com/RootsAnalysis
LinkedIn - https://www.linkedin.com/company/roots-analysis/mycompany/
Twitter - https://twitter.com/RootsAnalysis